<unk>  is a monoclonal antibody that is FDA approved for the treatment of B-cell chronic lymphocytic leukemia (B-CLL). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include cytopenias, infusion reactions, cytomegalovirus (CMV) and other infections, nausea, diarrhea and insomnia.
Alemtuzumab
Ruxolitinib
Bavituximab
Rituximab
Lenalidomide
Ibrutinib
Bosutinib
Acalabrutinib